$2,085 – $6,275

Life Science Investor Relations Forum (EXL)

Event Information

Share this event

Date and Time



The Revere Hotel Boston Common

200 Stuart Street

Boston, MA 02116

View Map

Friends Who Are Going
Event description


Life Science Investor Relations Forum

The Life Science Investor Relations Forum, taking place on September 7—8, 2017 in Boston, will bring together IR professionals to address the diverse set of challenges faced in the life sciences industry. Our expert speaking faculty will provide thought-provoking dialogue paired with networking opportunities that no other conferences address. IR teams are continuously balancing new regulations, advancements in technology, more engaged investors and working relationships with advisory boards. Through this event IR specialists will be able to efficiently gain the knowledge they need to improve their programs while developing a new network of educated IR colleagues. At this breakthrough, two-day conference we will provide our attendees with the solutions to the unique set of challenges IR teams encounter and enable them to be more effective in their jobs.

September 7 – 8, 2017 • Revere Hotel Boston Common • Boston, MA

Featured Session

Learn Best Practices for IR Professionals in M&A
  • Obtain a clear idea of what the parent company wants to achieve
  • Communicate challenges and connecting the communication needs of the Board of Directors, senior management and Wall Street
  • Understand legal and compliance challenges
  • Discuss how to navigate M&A in a public versus private company

Top Five Reasons to Attend

  1. Learn crisis communication specific to the life sciences industry
  2. Understand the best methods for dealing with the trials and distresses of an activist shareholder
  3. Address investor relation’s involvement in successful mergers and acquisitions
  4. Tackle the power of social media in 2017 and how it drives stock
  5. Examine the different interests of numerous shareholders that are geographically dispersed

Who Should Attend

  • Investor Relations
  • Public Relations
  • Communications
  • Media Relations
  • Investment Research
  • Corporate Investments
  • Stakeholder Relations
  • Investment Responsibility
  • Compliance

This event is also of interest to:

  • Consulting Firms
  • Financial Services
  • Proxy Solicitation and Corporate Advisory Firms
  • IR Research
  • Corporate Access Platform Providers


Day One
Thursday, September 7

8:00AM – 9:00AM

Registration and Continental Breakfast

9:00AM – 9:15AM

Chairpersons’ Opening Remarks

9:15AM – 10:00AM

Investor Relations – Overview for Life Sciences
Paul Cox, Senior Director, Investor Relations, SAGE THERAPEUTICS

10:00AM – 10:45AM

Manage the Changing Interests of Your Shareholders
Seth Lewis, Vice President Investor Relations, BAVARIAN NORDIC A/S

10:45AM – 11:15AM

Networking Break

11:15AM – 12:00PM

Analyst Perspective: Working Successfully With the Sell-Side
Salim Syed, Managing Director, Senior Biotechnology Analyst, Head of Biotechnology Research, MIZUHO SECURITIES USA

12:00PM – 1:00PM


1:00PM – 1:45PM

Prepare for and Responding to Activist Shareholders

1:45PM – 2:30PM

Generate Long-Term Value Under the Pressure of Short-Term Investor Priorities
Felicia Vonella, Executive Director, Investor Relations, ACORDA THERAPEUTICS

2:30PM – 3:15PM

Summarize the Best Crisis Communication Tactics for Professionals in the Life Sciences
Elif McDonald, Director, Investor Relations, VALEANT PHARMACEUTICALS

3:15PM – 3:45PM

Networking Break

3:45PM – 4:30PM

Stay Transparent While Clearly and Concisely Disclosing Bad News
Manisha Pai, Head of Investor Relations and Corporate Communications, BLUEBIRD BIO

4:30PM – 5:15PM

Modify Disclosure Management and External Communications in a Challenging Industry
Michelle Linn, Vice President Corporate Communications, AGENUS

5:15PM –

Day One Concludes

Day Two
Friday, September 8

8:00AM – 8:45AM

Continental Breakfast

8:45AM – 9:00AM

Chairpersons’ Recap of Day One

9:00AM – 9:45AM

Examine U.S. IPOs for International ADR Companies
Lucy Li, PhD, Associate Director, Strategy and Investor Relations, BEIGENE

9:45AM – 10:30AM

Design the Right Messages and Work With the Media
Christine Regan Lindenboom, Vice President, Investor Relations and Corporate Communications, ALNYLAM PHARMACEUTICALS

10:30AM – 11:00AM

Networking Break

11:00AM – 11:45AM

Engage With the Sell-Side and Extract Guidelines From the Source
Mark Vignola, Director, Investor Relations, INTERCEPT PHARMACEUTICALS
Vamil Divan, MD, MBA, Senior Research Analyst, CREDIT SUISSE

11:45AM – 12:30PM

Demonstrate How Your Executives’ Work Connects to the Street’s Perception of Shareholder Value
Sara Pellegrino, Senior Director, Investor Relations, AMICUS THERAPEUTICS

12:30PM – 1:30PM


1:30PM – 2:15PM

How to Prepare a Company for an Initial Public Offering
Bob Palladino, MBA, Chief Financial Officer, BIONEVIA

2:15PM – 3:00PM

Learn Best Practices for IR Professionals in M&A
Luba Greenwood, Vice President, Global Mergers & Acquisitions and Business Development, ROCHE

3:00PM – 4:00PM

Angel Investors and Venture Capitalists
Kyle Cetrulo, Co-Founder and Chief Executive Officer, AUXOCELL LABORATORIES

4:00PM –

Conference Concludes

Please contact the event manager Marilyn below for the following:
- Discounts for registering 5 or more participants.
- If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.

This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc.

SHU170502CEV MAR170707UPD MYL170731UPR

Share with friends

Date and Time


The Revere Hotel Boston Common

200 Stuart Street

Boston, MA 02116

View Map

Save This Event

Event Saved